We are live on
!
Find out more
Kymera Therapeutics
KYMR
KYMR
157 hedge funds and large institutions have $2.01B invested in Kymera Therapeutics in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 59 increasing their positions, 49 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more call options, than puts
Call options by funds: $961K | Put options by funds: $698K
20% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 49
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
0.2% less ownership
Funds ownership: 110.02% → 109.83% (-0.2%)
4% less funds holding
Funds holding: 164 → 157 (-7)
17% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 30
26% less capital invested
Capital invested by funds: $2.7B → $2.01B (-$691M)
Holders
157
Holders Change
-7
Holders Change %
-4.27%
% of All Funds
2.27%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
25
Increased
59
Reduced
49
Closed
30
Calls
$961K
Puts
$698K
Net Calls
+$263K
Net Calls Change
-$1.72M
Top Buyers
| 1 |
BlackRock
New York
|
+$17.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$16M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$15.3M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$8.78M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$8.23M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$26.4M |
| 2 |
JP Morgan Chase
New York
|
-$14.2M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$12.4M |
| 4 |
Barclays
London,
United Kingdom
|
-$9.38M |
| 5 |
Citigroup
New York
|
-$6.97M |